Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675775 · ClinicalTrials.gov registry record · NA
The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04675775 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 17 participants.
The verdict
NCT04675775, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is being completed for patients with cirrhosis, including patients with a prior history of hepatic encephalopathy (HE) to evaluate the feasibility and benefits of medically-tailored meals as an intervention. Patients will be enrolled from the University of Michigan and will complete the baseline assessments in-person or remotely. In addition participants will complete study related materials before, during and after treatment with medically-tailored meals (MTM). After completing the study meals, participants will return for follow-up or have this visit completed remotely as well as have an observational period for 12 more weeks.
Interventions
- OTHER Medically-tailored meals (MTM)
- DIETARY_SUPPLEMENT Protein supplements
- BEHAVIORAL Nutrition education handout
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2023-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04675775
The ClinicalTrials.gov registry entry for NCT04675775 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Medically-tailored meals (MTM) is the first listed.
NCT04675775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04675775 about?
NCT04675775 is a clinical study titled "The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.". This study is being completed for patients with cirrhosis, including patients with a prior history of hepatic encephalopathy (HE) to evaluate the feasibility and benefits of medically-tailored meals as an intervention. Patients will be enrolled from the University of Michigan and will complete the ...
What is the current status of trial NCT04675775?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2021-01-21. Estimated completion is 2023-03-05.
What interventions are being tested in trial NCT04675775?
The interventions under investigation include: Medically-tailored meals (MTM) (OTHER), Protein supplements (DIETARY_SUPPLEMENT), Nutrition education handout (BEHAVIORAL).
Who is sponsoring clinical trial NCT04675775?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.